The optimal management of patients on oral anticoagulation undergoing coronary artery stenting

One-Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry

(2014) Andrea Rubboli et al.   CLINICAL CARDIOLOGY

Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation

(2014) S. Silber et al.   EUROPEAN HEART JOURNAL

2014 ESC/EACTS Guidelines on myocardial revascularization

(2014)   EUROPEAN HEART JOURNAL

Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy

(2014) Tuomas Kiviniemi et al.   THROMBOSIS RESEARCH

Dabigatran Etexilate and Risk of Myocardial Infarction, Other Cardiovascular Events, Major Bleeding, and All‐Cause Mortality: A Systematic Review and Meta‐analysis of Randomized Controlled Trials

(2014) Jonathan Douxfils et al.   Journal of the American Heart Association

Frequency of Radial Artery Occlusion After Transradial Access in Patients Receiving Warfarin Therapy and Undergoing Coronary Angiography

(2013) Samir B. Pancholy et al.   AMERICAN JOURNAL OF CARDIOLOGY

Outcomes With Various Drug-Eluting or Bare Metal Stents in Patients With ST-Segment–Elevation Myocardial Infarction

(2013) Sripal Bangalore et al.   Circulation-Cardiovascular Interventions

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

(2013) Hein Heidbuchel et al.   EUROPACE

Triple Therapy With Aspirin, Prasugrel, and Vitamin K Antagonists in Patients With Drug-Eluting Stent Implantation and an Indication for Oral Anticoagulation

(2013) Nikolaus Sarafoff et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention

(2013) Morten Lamberts et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

(2013) Willem JM Dewilde et al.   LANCET

Anticoagulation in patients with atrial fibrillation undergoing coronary stent implantation

(2013) Anne Bernard et al.   THROMBOSIS AND HAEMOSTASIS

Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies

(2013) Jay Desai et al.   THROMBOSIS AND HAEMOSTASIS

Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation

(2013) Pilar Gallego et al.   THROMBOSIS AND HAEMOSTASIS

The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation

(2013) Laurent Azoulay et al.   THROMBOSIS AND HAEMOSTASIS

Vitamin K antagonists in heart disease: Current status and perspectives (Section III)

(2013) Raffaele Caterina et al.   THROMBOSIS AND HAEMOSTASIS

A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients

(2013) Pascal Vranckx et al.   EuroIntervention

Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology

(2013) Martial Hamon et al.   EuroIntervention

Comparison of Additional Versus No Additional Heparin During Therapeutic Oral Anticoagulation in Patients Undergoing Percutaneous Coronary Intervention

(2012) Tuomas Kiviniemi et al.   AMERICAN JOURNAL OF CARDIOLOGY

Perioperative Management of Antithrombotic Therapy

(2012) James D. Douketis et al.   CHEST

Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial

(2012) Antonio L. Dans et al.   CIRCULATION

Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis

(2012) Tullio Palmerini et al.   LANCET

Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting

(2011) John Eikelboom et al.   THROMBOSIS AND HAEMOSTASIS

Radial versus femoral access for orally anticoagulated patients

(2010) Antonios G. Ziakas et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data

(2009) Rikke Sørensen et al.   LANCET

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting

(2009) G. Y. H. Lip et al.   THROMBOSIS AND HAEMOSTASIS

Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation

(2008) Andrea Rubboli et al.   ANNALS OF MEDICINE

Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment

(2008) P. P. Karjalainen et al.   EUROPEAN HEART JOURNAL

ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

(2008) Deepak L. Bhatt et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Bivalirudin during Primary PCI in Acute Myocardial Infarction

(2008) Gregg W. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

(2007) Spencer B. King et al.   CIRCULATION